New Insights into Breast Cancer
Submission Deadline: 15 Aug 2022
Guest Editors

Medical School, University of Loannina, Loannina, Greece;European School of Oncology, Milan, Italy
Interests: cancer of unknown primary; cancer during pregnancy
Special Issue in IMR Press journals
Special Issue in New Insights into Breast Cancer - Volume 2

Medway NHS Foundation Trust, Gillingham, Kent, UK;AELIA Organization, Thessaloniki, Greece
Interests: ovarian cancer; cervical cancer; prostate cancer; renal cancer; colorectal cancer; cancer of unknown primary; cancer during pregnancy; metastatic spinal cord compression
Special Issue in IMR Press journals
Special Issue in New Insights into Breast Cancer - Volume 2
Special Issue Information
Dear Colleagues,
Breast cancer remains one of the most common cancer types in women. It is a heterogeneous disease with a number of molecular phenotypes. Advances in the field of molecular research have offered new insights into the cellular mechanisms and genetic changes that characterize breast cancer subtypes. This has allowed the identification of key driver genes and aberrations that initiate tumor development. Furthermore, the characterization of novel cellular targets has contributed to the development of improved therapeutic and diagnostic strategies.
This Special Issue on "New Insights into Breast Cancer" will gather reviews and original research articles that highlight recent advances in our understanding of the molecular basis of breast cancer, as well as novel therapeutic approaches. We invite researchers working on the personalized management of breast cancer using genomics and other biomarkers to contribute to this Special Issue. Finally, research relating to therapy resistance and novel approaches targeting tumor escape mechanisms will also be included in the scope of this Special Issue.
Prof. Nicholas Pavlidis and Dr. Stergios Boussios
Guest Editors
Keywords
- Breast cancer
- Personalized medicine
- Biomarkers
- Cancer stem cells
- Circulating tumor cells
- Cell signaling
- Molecular diagnostics
- Molecular profiling
- Targeted therapy
- Treatment resistance
Published Papers (3)
Landscape of Artificial Intelligence in Breast Cancer (2000–2021): A Bibliometric Analysis
Front. Biosci. (Landmark Ed) 2022, 27(8), 224; https://doi.org/10.31083/j.fbl2708224
(This article belongs to the Special Issue New Insights into Breast Cancer)
Combined Analysis of Disseminated Tumor Cells (DTCs) and Circulating Tumor DNA (ctDNA) in a Patient Suffering from Triple Negative Breast Cancer Revealed Elevated Risk
Front. Biosci. (Landmark Ed) 2022, 27(7), 208; https://doi.org/10.31083/j.fbl2707208
(This article belongs to the Special Issue New Insights into Breast Cancer)
Anti-cancer Drug Anlotinib Promotes Autophagy and Apoptosis in Breast Cancer
Front. Biosci. (Landmark Ed) 2022, 27(4), 125; https://doi.org/10.31083/j.fbl2704125
(This article belongs to the Special Issue New Insights into Breast Cancer)
